Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sleep quality after general anesthesia
ChiCTR2400079610Phase 4Recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in sleep disorder (2 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoints: Subjective sleep improvement and Objective sleep improvement at 48 hours after surgery. Started Jan 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2400079610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079610.